Edesa Biotech Inc (EDSA)
4.38
+0.12
(+2.82%)
USD |
NASDAQ |
Jun 21, 16:00
4.85
+0.47
(+10.73%)
Pre-Market: 08:35
Edesa Biotech SG&A to Revenue (TTM)
SG&A to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A to Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
| September 30, 2016 | -- |
| June 30, 2016 | -- |
| March 31, 2016 | -- |
| December 31, 2015 | -- |
| Date | Value |
|---|---|
| September 30, 2015 | -- |
| June 30, 2015 | -- |
| March 31, 2015 | -- |
| December 31, 2014 | -- |
| August 31, 2014 | -- |
| May 31, 2014 | -- |
| February 28, 2014 | -- |
| November 30, 2013 | -- |
| August 31, 2013 | -- |
| May 31, 2013 | -- |
| February 28, 2013 | -- |
| November 30, 2012 | -- |
| August 31, 2012 | -- |
| May 31, 2012 | -- |
| February 29, 2012 | -- |
| November 30, 2011 | -- |
| August 31, 2011 | -- |
| May 31, 2011 | -- |
| February 28, 2011 | -- |
SG&A to Revenue Definition
SG&A to Revenue is a ratio that compares a company's Sales, General, and Administrative Expenses to its total revenue. SG&A to Revenue can be used to measure the efficiency of a company's cost management. SG&A expenses include costs such as salaries, marketing expenses, rent, utilities, office supplies, and other operational expenses that are not directly tied to the production of goods or services. By comparing these expenses to total revenue, the ratio helps assess how effectively a company...